Background: An epimeric form of 25-hydroxyvitamin D 3 (25(OH)D 3 ) has recently been detected in clinical samples, with relatively high levels in infants. Little is known on 3-epi-25(OH) D 3 formation and physiological function. Our objective was to study dynamics of 3-epi-25(OH)D 3 formation during infancy. Methods: 25(OH)D 3 and 3-epi-25(OH)D 3 levels were measured by liquid chromatography-tandem mass spectrometry in 22 preterm (aged 34-37 wk), 15 early preterm (aged <34 wk), and 118 term infants up to 2 y of age. All infants were prescribed vitamin D 400 IU/day after the first week of life. results: At birth, 3-epi-25(OH)D 3 levels were 3 (1-7) nmol/l, <10% of total 25(OH)D 3 . From the second week to 3 mo of age, both 25(OH)D 3 and 3-epi-25(OH)D 3 increased, with highest 3-epi-25(OH)D 3 contribution in early preterm infants (up to 55% of total 25(OH)D 3 vs. 36% in term infants, P < 0.0001). After 3 mo of age, 3-epi-25(OH)D 3 normalized to <10% in all infants. conclusions: At birth, all infants showed low contribution of 3-epi-25(OH)D 3 , increasing the week after starting vitamin D supplementation, until 3 mo of age. Highest levels of 3-epi-25(OH)D 3 were found in early preterm infants, supporting the hypothesis that hepatic immaturity plays a role in 3-epi-25(OH) D 3 formation.
V
itamin D has garnered a great deal of attention in recent years due to a global prevalence of vitamin D deficiency associated with an increased risk of a variety of human diseases (1) (2) (3) . Specifically, hypovitaminosis D in pregnant women is highly common and has important implications for the mother and lifelong health of the child, since it has been linked not only to rickets but also to maternal and child infections, small for gestational age, preterm delivery, pre-eclampsia, gestational diabetes, as well as imprinting on the infant for life chronic diseases (4, 5) .
Transplacental passage of maternal 25-hydroxyvitamin D 3 (25(OH)D 3 ) is the sole source of vitamin D in the developing fetus and implicates that infants are wholly reliant on their mother for their vitamin D status. Given the high prevalence of hypovitaminosis D in pregnant women, supplements are the best way to prevent vitamin D deficiency in infants. Various international committees (e.g., American Academy of Paediatrics Committee on Nutrition or the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)) recommend to provide 400 IU/day of vitamin D to all infants (breastfed, healthy term babies) as a generally safe and efficacious measure to prevent rickets (6, 7) . For neonatal care, questions remain, such as the optimal vitamin D dose and vitamin D status for preterm, late-preterm, formula-fed, and breastfed term infants (8) (9) (10) .
It is accepted that the best available marker of vitamin D exposure and vitamin D status is the serum 25(OH)D concentration (11) . There is a strong correlation between maternal and infant cord blood 25(OH)D concentrations, cord blood concentration being slightly less than maternal concentrations (12) .
The interpretation of serum 25(OH)D concentrations in infants is complicated by the presence of a C 3 -epimeric form of 25(OH)D (3-epi-25(OH)D), a vitamin D metabolite that has been shown in infants up to 1 y of age to contribute up to 61% of total 25(OH)D. Serum 3-epi-25(OH)D can be erroneously included as 25(OH)D if immunoassays are used that display cross-reactivity to the C 3 -epimer or with high-performance liquid chromatography or liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods that do not resolve both compounds (13) .
At present, the source of the C 3 -epimer (i.e., diet, supplements, endogenous metabolism) and factors underlying 25(OH)D epimerization are still unclear (14) . Also, the physiological importance of the C 3 -epimer is heavily debated. In vitro work and rodent models show that 3-epi-25(OH) D 3 and the epimeric form of calcitriol (3-epi-1α,25(OH) 2 D 3 ) bind vitamin D binding protein at 36-46% and vitamin D receptor at 2-3% as compared with non-epimer 25(OH)D 3 and calcitriol (15) . However, 3-epi-1α,25(OH) 2 D 3 appears nearly as potent as calcitriol in suppressing parathyroid hormone (16) , but it has significantly reduced calcemic effects (17) . A detailed review of the metabolic pathway and physiological functions of C 3 -epimer forms of vitamin D can be found elsewhere (14) .
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Little is known on the time course of C 3 -epimer formation over the first years of life. Our objective was to study the dynamics of 3-epi-25(OH)D 3 and 25(OH)D 3 formation during infancy by 25(OH)D 3 and 3-epi-25(OH)D 3 measurement in plasma from preterm and term infants from birth up to 2 y of age.
RESULTS
Baseline characteristics are shown in Table 1 . Figure 1 shows the time course of 25(OH)D 3 and 3-epi-25(OH)D 3 formation from birth up to 2 y of age. In 8.5% of all samples, all confined to first week sample collections, 3-epi-25(OH)D 3 concentrations were below the detection limit of 1 nmol/l. 25(OH)D 2 concentrations were below detection limit (2 nmol/l) in all 316 samples.
Time Course of 25(OH)D 3 Concentrations
At birth, mean (range) 25(OH)D 3 levels were 39 (7-112) nmol/l with 77% showing vitamin D insufficiency (<50 nmol/l). Levels remain more or less unchanged in the first week. From the third week of life 25(OH)D 3 levels increase, probably explained by the start of 400 IU/day vitamin D supplementation starting at day 7-10. From the first month to 1 y 
Prematurity as a Determinant of 3-epi-25(OH)D 3 Formation
We speculated that prematurity could be a factor influencing C 3 -epimer formation. We therefore categorized the infants into three groups of gestational age: <34 wk preterm, >34 wk preterm, and term. When observing the first 3 mo, the highest 25(OH)D 3 concentrations belong to the preterm infants born at <34 wk of gestation. Even more striking is the marked increase of the C 3 -epimer concentration from day 10 on in this group, as compared with the full term and >34 wk preterm groups (Figures 1 and 2) , with relative 3-epi-25(OH)D 3 contribution up to 55% in early preterm infants, vs. 36% in fullterm infants (P < 0.0001; Figure 1 ). Particularly for the early preterm state, an inverse relationship is seen between the gestational age and the 3-epi-25(OH)D 3 concentration (Figure 3 ). In the term infant population a similar, although less pronounced, rise and fall in C 3 -epimer formation is seen. This same trend is seen for birth weight, however, when taking P values for gestational age into account, this trend is clearly related to gestational age rather than birth weight solely (data not shown). No correlation was found between bilirubin value, C-reactive protein (CRP) value, phototherapy, and use of medication regarding height of 3-epi-25(OH)D 3 concentration. Articles Ooms et al.
Plasma 25(OH)D 3 Correlation With 3-epi-25(OH)D 3
Plasma 25(OH)D 3 concentrations correlate positively with 3-epi-25(OH)D 3 in a curved-linear relationship. When the three categories of gestational age (<34 wk preterm, >34 wk preterm, and term) are plotted separately, two distinct positive linear relationships can be found: one from the <34 wk group and a pooled one from the term and >34 wk preterm group (the latter groups do not significantly differ from one another (Figure 4a) . Relative 3-epi-25(OH)D 3 contribution to 25(OH) D 3 shows a hyperbolic relationship in the <34 wk preterm group (Figure 4b) .
Origin of 3-epi-25(OH)D 3
We examined the presence of appreciable amounts of 3-epivitamin D 3 in the liquid vitamin D supplements prescribed from the second week of life. 3 . In a recent cohort study of mother-infant pairs, it was shown that 3-epi-25(OH)D 3 is present at low levels in some pregnant women and fetuses but does not appear to be efficiently transferred transplacentally (20) . It was speculated that high C 3 -epimer concentrations in infancy are probably due to postnatal formation rather than fetal stores. We can confirm low 3-epi- (15) . The function of this pathway remains unknown, as well as the explanation for the absence of its activity after the age of 3 mo.
Prematurity as a Major Determinant of C 3 -Epimer Formation
Singh et al. (13) have shown for the first time that within a group of infants <1 y of age, C 3 -epimer formation is inversely correlated with age suggesting that high rates of C 3 -epimerization might be a function of possibly hepatic, immature vitamin D metabolism. Our results show a typical rise and fall of C 3 -epimer over a 3-mo period of time that is most pronounced in early preterm infants. Our findings differ from those of Granado-Lorencio et al. (22) who found higher levels of 25(OH)D3 and C3-epimer in term infants compared with preterm infants. The preterm status is likely to be associated with immature vitamin D metabolism that may favor 3-epi-25(OH)D 3 epimerization. Epimerization appears to employ enzymes distinct from the classical hepatic enzyme systems (13) . As epimerization appears to be a common mechanism for all major vitamin D metabolites, it will be interesting to investigate C 3 -epimer forms of other vitamin D metabolites in plasma from preterm infants in search for similar effects.
Risk of Over-Supplementation
Gallo et al. The quantity and effectiveness of vitamin D supplementation in preterm infants remain unclear, they are not always specified in current recommendations or range from 200 to 1,000 IU/day (8) . Adding to the confusion is a paucity of highquality prospective studies and limited information regarding toxicity. Organ system immaturity in preterm infants is connected with long-term complications that have both clinical and public health importance.
A possible explanation for the high 25(OH)D 3 concentrations in preterm infants is their minimal fat mass in which vitamin D and its metabolites are stored. This means that on a body-weight basis, the intake may be 5 to 10 times the amount recommended for term neonates (8) . As a consequence, the majority of vitamin D is immediately metabolized to 25(OH) D, remains in the circulation, and may be further metabolized. Our preliminary findings question the safety of current recommendations for vitamin D supplementation in preterm infants. As a precautionary measure, we would like to recommend these to lower levels, in particular in those with (extremely) low fat mass.
The markedly elevated levels of 3-epi-25(OH)D 3 , reflecting 3-epi-epimerase activity, may suggest some kind of mechanism to avoid high vitamin D exposure (and/or elevated plasma 25(OH)D concentrations) in preterm infants. Therefore, it would be interesting to have information on 24,25-dihydroxyvitamin D3 (24,25(OH) 2 D 3 ) levels as an indicator of 25(OH)D inactivation. Unfortunately, we did not measure 24,25(OH) 2 D 3 . An alternative explanation for the elevated levels of C 3 -epimer is increased 3-epimerase activity from hepatic immaturity, for reasons yet unknown. Functionality, as well as the mechanism, leading to C 3 -epimer formation remains a topic for further research. It remains to be seen whether 3-epi-25(OH)D 3 could serve as a marker of hepatic immaturity.
Concerns of Assay Methodology
Multiple studies on 25 Compliance is a major issue in supplementation programs. However, the infants involved in this study were not extremely premature and generally in good condition. In the majority of infants, it was therefore possible to administer vitamin D 400 IU/day after the first week of life, but the adherence after hospital discharge may have been suboptimal.
Since the Dutch Health Council advises all children 0-4 y of age 400 IU per day extra starting at day 8 after birth, it is not possible to study infant 25(OH)D 3 and 3-epi-25(OH)D 3 dynamics in the absence of exogenous vitamin D, at least in The Netherlands. Scarce data are available on 3-epi-25(OH)D 3 formation in infants not receiving vitamin D supplementation. The only data we are aware of is a study in Bangladesh infants aged 3-28 wk in whom the absolute concentration of 25(OH) D 3 was observed to increase with age (range 20-120 nmol/l), whereas 3-epi-25(OH)D 3 concentrations remained constant (0-17 nmol/l), resulting in a decline in the relative contribution of the C 3 -epimer over time (0-25%) (20) . Unfortunately, information on gestational status was lacking. Further studies in infants with and without vitamin D supplementation are needed to provide more conclusive evidence on the role of exogenous vitamin D as a contributing factor of high C3-epimer formation in infants.
In conclusion, we have shown here that the highest 25(OH) D 3 as well as 3-epi-25(OH)D 3 levels are found in preterm infants within a 30-to 90-d period. Main contributors to C 3 -epimer are endogenous formation, most likely depending on vitamin D supplementation as well as early preterm state. This supports the hypothesis that hepatic immaturity may play a role in 3-epi-25(OH)D 3 formation. It also suggests that C 3 -epimerization could be a major metabolic pathway for 25(OH) D 3 under certain circumstances. The highly elevated 25(OH) D 3 and 3-epi-25(OH)D 3 concentrations in preterm infants raises concerns on the safety of current vitamin D dosing using 400 IU/day in this particular group and requires further investigation.
METHODS

Sample Collection
Between February and June 2014, we collected left over plasma samples of infants and children between 0 d and 2 y of age. Indications for blood sampling were to determine infection status (CRP), follow-up of jaundice (bilirubin) or thyroid function. In total, 316 samples were collected from 163 individual patients. In 14 cases, two blood samples taken at closely related time points were pooled to obtain sufficient material for vitamin D analysis.
The study was approved by the Canisius-Wilhelmina Hospital Institution Review Board. Parental informed consent was not required as left over plasma samples from routine diagnostics were used. The Dutch Health Council dietary reference intakes and supplementation advice for vitamin D (2012) advises all children 0-4 y of age 400 IU per day extra starting at day 8 after birth, ensuring adequate intake to prevent rickets (27) . The guideline does not mention the specific vitamin D needs of preterm infants.
Data of patient characteristics such as age, gestational age, birth weight, indication for blood sampling, bilirubin and CRP value (if known), use of phototherapy, and use of medication were obtained from the patient's file. 
Biochemical Measurements
Statistical Analysis
ANOVA were used for between-group comparisons (25(OH)D 3 , absolute and relative 3-epi-25(OH)D 3 vs. gestational age (<34 wk, 34-37 wk, ≥37 wk)). Univariate associations were assessed using Pearson's correlation coefficient. Statistical significance was set at P < 0.05. Data were collected and analyzed using the SPSS statistical software for Windows (v.21.0, SPSS inc, Chicago. IL).
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